(Q39316382)
Statements
1 reference
A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome (English)
1 reference
K Matsueda
1 reference
S Harasawa
1 reference
M Hongo
1 reference
N Hiwatashi
1 reference
D Sasaki
1 reference
10 June 2008
1 reference
1 reference
77
1 reference
3-4
1 reference
225-235
1 reference
Identifiers
1 reference
1 reference